Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluticasone propionate + albuterol sulfate
- Development stage
- Phase 3
- Lead developer
- Teva Pharmaceutical
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation
01
Overview
Fluticasone propionate + albuterol sulfate is a fixed-dose combination inhalation therapy under development, combining an inhaled corticosteroid (fluticasone propionate) and a short-acting beta 2 adrenergic receptor agonist (albuterol sulfate). Fluticasone acts by binding to glucocorticoid receptors, reducing inflammation in the airways, while albuterol stimulates beta 2 adrenergic receptors to relax bronchial smooth muscle and provide rapid bronchodilation. This combination is being developed primarily for the treatment of asthma, aiming to both control chronic airway inflammation and provide quick relief from bronchospasm. The product is currently in Phase III clinical trials for asthma in adolescents and adults[4].
- Other names
- fluticasone propionate/albuterol sulfatesalbutamol sulfate/fluticasone propionate
02
Targets
ADRB2 (β2)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on fluticasone propionate + albuterol sulfate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluticasone propionate + albuterol sulfate.